Literature DB >> 903182

Inhibition of the growth of lymphoid tumours in syngeneic athymic (nude) mice.

N L Warner, M F Woodruff, R C Burton.   

Abstract

A comparison of the growth of a number of BALB/c tumours in BALB/c, BALB/c.nu/ + (heterozygous nude) and BALB/c.nu (homozygous) nude mice has shown that a majority of BALB/c lymphoid tumours grow at a significantly reduced rate in BALB/c.nu mice. The three non-lymphoid BALB/c tumours (carcinomas and sarcomas) tested and a minority of lymphoid tumours, however, grew as well, or better, in the BALB/c.nu mice. Furthermore a correlation, without exception to date, has emerged from a comparison between the susceptibility of a tumour cell line to in vitro lysis by spleen cells from syngeneic nude mice and its growth in vivo in syngeneic nude mice. Only those lymphoid tumour cell lines lysed in vitro show the reduced growth rate in syngeneic nude as compared to syngeneic normal mice. Tumour cell lines, both lymphoid and non-lymphoid, which are resistant to in vitro lysis do not show the reduced in vivo growth rate in syngeneic nude mice. Both the in vivo and in vitro effect can be partially abolished by irradiating the nude mice prior to use, suggesting that a radiation-sensitive non-T-cell surveillance of lymphoid tumours is operating in nude mice. While the identity of the antigens is still unknown, the specificity of the phenomena suggest that C-type RNA oncogenic viral determined antigens are involved.

Entities:  

Mesh:

Year:  1977        PMID: 903182     DOI: 10.1002/ijc.2910200122

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Inhibition of mammary tumorigenesis in virgin rats by adoptive transfer of splenocytes from parous donors.

Authors:  P K Chakravarty; D K Sinha
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.

Authors:  R Maccario; A G Ugazio; L Nespoli; C Alberini; D Montagna; F Porta; F Bonetti; G R Burgio
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

3.  Study of the effect of single or multiple doses of BCG on antibody-dependent cellular cytotoxicity.

Authors:  N Kiger; M Bruley-Rosset; R Huchet; G Mathe
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

4.  Natural killer cell activity in inflammatory joint disease.

Authors:  R D Armstrong; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

5.  In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.

Authors:  O Sorensen; R Dugre; D Percy; S Dales
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

6.  Natural resistance against hematopoietic cells in lethally-irradiated mice infected with Friend leukemia virus.

Authors:  A M Iorio; M Neri; P Enrico; F Titti; G B Rossi; E Bonmassar
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Evaluation of in vivo and in vitro effectivity of immune defense against a spontaneously arising, nonlymphoid rat tumor. I. Analysis of natural immune defense.

Authors:  M Zöller
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  Analysis of natural killer effector and suppressor activity by intraepithelial lymphocytes from mouse small intestine.

Authors:  A M Mowat; R C Tait; S MacKenzie; M D Davies; D M Parrott
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

9.  Suppression of malignancy in human cancer cells: issues and challenges.

Authors:  A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Role of natural killer cells in control of cancer metastasis.

Authors:  N Hanna
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.